HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takahiro Tsukimura Selected Research

globotriaosyl lysosphingolipid

9/2021Does administration of hydroxychloroquine/amiodarone accelerate accumulation of globotriaosylceramide and globotriaosylsphingosine in Fabry mice?
7/2015Clinical and biochemical investigation of male patients exhibiting membranous cytoplasmic bodies in biopsied kidney tissues; a pitfall in diagnosis of Fabry disease.
1/2015Nano-LC-MS/MS for Quantification of Lyso-Gb3 and Its Analogues Reveals a Useful Biomarker for Fabry Disease.
1/2014Plasma mutant α-galactosidase A protein and globotriaosylsphingosine level in Fabry disease.
11/2012Mutant α-galactosidase A with M296I does not cause elevation of the plasma globotriaosylsphingosine level.
9/2010Tissue and plasma globotriaosylsphingosine could be a biomarker for assessing enzyme replacement therapy for Fabry disease.
7/2010Plasma globotriaosylsphingosine as a biomarker of Fabry disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takahiro Tsukimura Research Topics

Disease

26Fabry Disease (Fabry's Disease)
12/2021 - 04/2009
5Inborn Genetic Diseases (Disease, Hereditary)
01/2014 - 07/2010
2Lysosomal Storage Diseases (Lysosomal Storage Disease)
09/2021 - 12/2020
2Sandhoff Disease (Sandhoff's Disease)
01/2017 - 01/2011
2Mucopolysaccharidosis I (Hurler Syndrome)
09/2013 - 09/2008
2Glycogen Storage Disease Type II (Pompe's Disease)
06/2011 - 01/2007
1Chronic Renal Insufficiency
12/2021
1Azoospermia
01/2020
1Proteinuria
12/2019
1Nephrotic Syndrome (Syndrome, Nephrotic)
12/2019
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
12/2019
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
01/2017
1Gliosis
01/2017
1Wilms Tumor (Wilm's Tumor)
05/2015
1Chronic Kidney Failure (Chronic Renal Failure)
09/2012
1Heart Diseases (Heart Disease)
04/2012
1Tay-Sachs Disease
01/2011
1Hypersensitivity (Allergy)
11/2009

Drug/Important Bio-Agent (IBA)

14GalactosidasesIBA
12/2021 - 05/2011
9globotriaosylceramide (globotriosylceramide)IBA
12/2021 - 11/2009
9EnzymesIBA
01/2021 - 04/2009
7globotriaosyl lysosphingolipidIBA
09/2021 - 07/2010
6Biomarkers (Surrogate Marker)IBA
08/2018 - 07/2010
5alpha-Galactosidase (Beano)IBA
01/2021 - 04/2009
4GlycosphingolipidsIBA
01/2017 - 02/2012
3GlycolipidsIBA
12/2021 - 09/2010
3Proteins (Proteins, Gene)FDA Link
01/2014 - 11/2009
3Imino SugarsIBA
06/2011 - 04/2009
2agalsidase alfaIBA
12/2020 - 02/2012
2agalsidase betaFDA Link
12/2020 - 01/2015
2Protein Isoforms (Isoforms)IBA
01/2017 - 01/2015
2AntibodiesIBA
05/2015 - 01/2015
2Iduronidase (alpha-L-Iduronidase)IBA
09/2013 - 09/2008
2Polysaccharides (Glycans)IBA
09/2013 - 02/2012
2NucleotidesIBA
09/2012 - 04/2012
1Phospholipids (Phosphatides)FDA LinkGeneric
09/2021
1Pharmaceutical PreparationsIBA
09/2021
1CationsIBA
12/2020
1Mannose (D-Mannose)IBA
12/2020
1CollagenIBA
01/2020
1Peptides (Polypeptides)IBA
01/2020
1Protamines (Protamine Sulfate)FDA Link
01/2020
1SteroidsIBA
12/2019
1Cyclosporine (Ciclosporin)FDA LinkGeneric
12/2019
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2017
1G(M2) Ganglioside (Ganglioside GM2)IBA
01/2017
1Hexosaminidases (Hexosaminidase)IBA
01/2017
1AutoantibodiesIBA
01/2017
1Fingolimod Hydrochloride (FTY720)FDA Link
01/2017
1podocalyxinIBA
05/2015
1VimentinIBA
05/2015
1migalastatIBA
07/2014
1Heparitin Sulfate (Heparan Sulfate)IBA
09/2013
1Glycoproteins (Glycoprotein)IBA
02/2012
1Hexosaminidase A (Hex A)IBA
01/2011
1GangliosidesIBA
01/2011
1lysoganglioside G(M2)IBA
01/2011
1alpha-N-Acetylgalactosaminidase (N-Acetyl-alpha-D-Galactosaminidase)IBA
11/2009
1Mutant Proteins (Protein, Mutant)IBA
01/2007
1Nonsense Codon (Nonsense Mutation)IBA
01/2007
1AcidsIBA
01/2007
1alpha-Glucosidases (Acid Maltase)IBA
01/2007

Therapy/Procedure

9Enzyme Replacement Therapy
12/2020 - 11/2009
4Therapeutics
01/2020 - 04/2009
2Cell Transplantation
01/2021 - 01/2020
1Immunotherapy
12/2019
1Renal Dialysis (Hemodialysis)
09/2012